Immune system’s redesigned role in fighting cancerous tumors — ScienceDaily
source : http://www.sciencedaily.com/releases/2014/03/140312103145.htm
source : http://www.sciencedaily.com/releases/2014/03/140312103145.htm
source : http://www.sciencedaily.com/releases/2014/01/140125172207.htm
Seven of the 16 participants still are living, with length of survival ranging from 60.7 to 82.7 months after diagnosis. …
Investigators in the Cedars-Sinai Samuel Oschin Comprehensive Cancer Institute have made extensive progress in understanding the molecular mechanisms of disease progression. These results may help scientists better understand the prognosis of patients diagnosed with advanced prostate cancer. The study, published in the journal Cell Cycle and led by Dolores Di Vizio, MD, PhD, may ultimately lead to the development of new biomarkers for not only prognosis, but also a patient’s potential response to therapy. "One of the long-standing difficulties in treating men with advanced prostate cancer has been predicting the response to given therapies or treatments," said Di Vizio, associate professor in the Department of Surgery, Department of Pathology and Laboratory Medicine and Department of Biomedical Sciences. …